Internal Medicine, Gastroenterology · Salina, KS
NPI
1265497002
Since 2006
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
737 E Crawford St
Salina, KS, 67401
Phone (785) 827-7261
Medicare paid, 2024
$88K
1,218 services
Medicare patients, 2024
606
Average age 72
Drug cost, 2024
$2.2M
1,722 prescriptions
Company payments, 2024
$287
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Lavelle A Ellis was code 99213 (office e&m - established), 112 times for 110 patients. In total Lavelle A Ellis billed 1,218 services in 67 codes, and Medicare paid $88K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-04-01.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 112 | 110 | $58.40 | $6,540 |
| 45385 Colonoscopy - Lesion Removal | Facility | 92 | 92 | $181.82 | $17K |
| 99214 Office E&M - Established | Office | 80 | 72 | $74.25 | $5,940 |
| 36415 Venipuncture Blood Collection | Office | 78 | 52 | $8.65 | $675 |
| 43235 Upper GI Endoscopy | Facility | 70 | 70 | $71.80 | $5,026 |
| 43239 Upper GI Endoscopy | Facility | 61 | 59 | $59.35 | $3,620 |
| 99214 Office E&M - Established | Facility | 51 | 47 | $60.94 | $3,108 |
| 43249 Upper GI Endoscopy | Facility | 47 | 46 | $85.03 | $3,997 |
| 45380 Lower GI Endoscopy - Other | Facility | 45 | 44 | $114.10 | $5,135 |
| 85025 Blood Count | Office | 40 | 26 | $7.61 | $304 |
| 80053 Clinical Chemistry | Office | 38 | 23 | $10.35 | $393 |
| G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 33 | 33 | $165.42 | $5,459 |
| 99213 Office E&M - Established | Facility | 32 | 32 | $39.00 | $1,248 |
| 99232 Hospital E&M - Subsequent | Facility | 29 | 17 | $57.97 | $1,681 |
| 45378 Lower GI Endoscopy - Other | Facility | 27 | 27 | $127.38 | $3,439 |
By year: 2022 $123K for 1,775 services; 2023 $127K for 1,681 services; 2024 $88K for 1,218 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 78 | 52 | $8.65 | $675 |
| 85025 Blood Count | 40 | 26 | $7.61 | $304 |
| 80053 Clinical Chemistry | 38 | 23 | $10.35 | $393 |
| 85610 Clinical Chemistry | 27 | 17 | $4.20 | $113 |
| 85730 Clinical Chemistry | 18 | 14 | $5.89 | $106 |
| 80076 Clinical Chemistry | 16 | 16 | $8.01 | $128 |
| 89055 General Laboratory | 11 | 11 | $4.18 | $45.98 |
Medicare prescription drug claims, 2024
In 2024, the drug Lavelle A Ellis prescribed most often to Medicare patients was Colestipol Hcl, with 184 prescriptions and refills. In total Lavelle A Ellis wrote 1,722 Medicare prescriptions that cost $2.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Colestipol Hcl Generic | 184 | 261 | 48 | $8,279 |
| Omeprazole Generic | 170 | 322 | 48 | $1,373 |
| Metoclopramide Hcl Generic | 92 | 118 | 25 | $641 |
| Pantoprazole Sodium Generic | 81 | 154 | 25 | $1,027 |
| Sulfasalazine Generic | 74 | 112 | 14 | $2,583 |
| Azathioprine Generic | 74 | 116 | 12 | $4,303 |
| Gavilyte-G Peg3350/Sod Sulf,bicarb,cl/Kcl | 71 | 71 | 68 | $1,084 |
| Mesalamine Generic | 56 | 91 | Under 11 | $30K |
| Ursodiol Generic | 56 | 96 | Under 11 | $7,115 |
| Balsalazide Disodium Generic | 51 | 83 | 12 | $7,249 |
| Ocaliva Obeticholic Acid | 49 | 49 | Under 11 | $462K |
| Stelara Ustekinumab | 44 | 75 | Under 11 | $1.2M |
| Creon Lipase/Protease/Amylase | 39 | 47 | Under 11 | $118K |
| Famotidine Generic | 36 | 88 | 12 | $252 |
| Linzess Linaclotide | 33 | 35 | Under 11 | $19K |
Brand drugs: 520 claims; generic drugs: 1,202 claims.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Lavelle A Ellis $287 ($287 in general payments such as food, travel and fees) from 9 companies. The largest payer was Abbvie Inc. with $67.2.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 4 | $67.2 |
| Lilly USA, LLC LLY | 2 | $59.92 |
| Intercept Pharmaceuticals, Inc. | 3 | $53.49 |
| Sandoz Inc. SDZ.SW | 1 | $21.46 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 1 | $21.34 |
| Merck Sharp & Dohme LLC MRK | 1 | $19.31 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 1 | $16.96 |
| Celltrion USA Inc. 068270.KS | 1 | $14.57 |
| Phathom Pharmaceuticals, Inc. PHAT | 1 | $13.14 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.